Navigation Links
Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
Date:4/21/2009

osses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2009 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James ... Dr. Cottrell has been making predictions about the economy, politics, social issues, as ... these prognostications. He warns that extreme weather conditions and increased earthquake / volcanic ...
(Date:7/29/2015)... Carolina (PRWEB) , ... July 29, 2015 , ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits and ... Challenge North Carolina inclusive sporting event taking place in Charlotte, North Carolina ...
(Date:7/29/2015)... ... July 29, 2015 , ... One ... for a study on the potentially lifesaving impact of removing aluminum from Alzheimer’s ... , The research proposal is based on a successful pilot study published in ...
(Date:7/29/2015)... ... July 29, 2015 , ... One may not expect ... assisted nursing facility, but that’s exactly what was happening on the campus of ... are 3- and 4-year-olds from Kids Only , a five-star childcare center which ...
(Date:7/28/2015)... VA (PRWEB) , ... July 29, 2015 , ... Talking ... Aug. 18, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , ... they can — and can’t — say about it is tightly regulated by the ...
Breaking Medicine News(10 mins):Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4
... British soldiers who are suffering from mental illness after ... wait 18 months or longer for treatment// from the ... the figures released by British Ministry of Defence (MoD) ... mental health conditions after returning from Iraq since 2003. ...
... American is part of a team of scientists who have ... that suppresses the growth of cancer// tumors in humans. ... the Cold Spring Harbor Laboratory (CSHL), a private research institute ... which if faulty allows human cells to misbehave and tumors ...
... Describing the causes of heart disease as a thousand piece ... University of Pittsburgh//, have admitted to putting at least one ... of her study, which attempted to connect genetics, emotions and ... , Studying around 550 women of European descent, across ...
... bacteria faster than the current laboratory based detection, which ... ,Sheila MacNeil and researchers at Sheffield University ... of bacteria in less then a minute by using ... ,The technology could have wide applications in wound ...
... by the British Snoring and Sleep Apnoea Association (BSSAA) reveals ... has a detrimental effect on health and ruins sex lives. ... has brought out an anti snore bedroom which has suspension ... and aid people who suffer from dust and nasal congestion. ...
... Hopkins emergency medicine specialists have developed a tool ... potential to overwhelm services//. ,The Electronic Mass ... calculates the impact of such crises as a ... accounting for such elements as numbers of victims, ...
Cached Medicine News:
(Date:7/28/2015)... 2015 Research and ... of the "Craniomaxillofacial Implants Market - Global ... 2014 - 2022" report to their offering. ... market studies the current and future prospects of ... popularity in the global market due to increasing ...
(Date:7/28/2015)... , July 28, 2015 The Physician-Patient ... patient safety fundraising campaign, " Surviving Your Hospital Stay ... the care they deserve! None of these patients went ... (Founder and Executive Director, PPAHS) referring to the ... the National Coalition to Promote Continuous Monitoring of ...
(Date:7/28/2015)... BIRMINGHAM, Ala. , July 28, 2015   ... butler for surgeons , has just hired John ... and Business Development. John has over 30 years of ... executive roles. Mr. O,Neil,s executive healthcare experience coupled with ... an active surgeon allows Vincari to address the challenges ...
Breaking Medicine Technology:Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... Inc. (OTCQB: SCLR) announced today that it updated their ... details for their products currently available.  The most current ... www.scolr.com under the "Specialty Supplements" section of ... home page or the navigation bar at the top.  ...
... March 2, 2012 Groupe Athena, Inc. (Pink sheets ... which indicate possible outcomes and are provided to assist ... Athena, Inc. believes that these forecasts represent the best ... may differ from these forecasts, and such differences could ...
Cached Medicine Technology:SCOLR Pharma, Inc. Provides Product Information on Website 2Groupe Athena, Inc. Clarifies Previous Guidance, Addresses U.S. Drug Shortage 2Groupe Athena, Inc. Clarifies Previous Guidance, Addresses U.S. Drug Shortage 3
... Biomet Ankle Arthrodesis ... suited for,tibiotalocalcaneal fusion ... nail affords rigid, ... that incorporates a,simple ...
... clinical and economic issues of cerclage wiring, ... to maximize tension control while minimizing invasion ... efficient instrumentation with a simple technique. , ... indicated for general orthopaedic trauma surgery involving: ...
OmniAccess&trade Hip Retractor System sets a new standard in hip exposure. It provides constant, absolute exposure of the acetabulum during total hip arthroplasty and revision procedures....
... DePuy's aggressive innovations have become the accepted ... equalled. The AML Total Hip System ... address and effectively meet the needs for ... With greater than 15 years of documented ...
Medicine Products: